A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 1, 1997, Pages 111-116

  Blanke, C ^a,c   Devore, R ^a   Shyr, Y ^a   Epstein, B ^a   Murray, M ^b   Hande, K ^a   Stewart, S ^a   Johnson, D ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Radiation Oncology   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Chemotherapy; Combined modality therapy; Locally advanced nonsmall cell lung cancer; Radiotherapy; Toxicity

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; STOMATITIS; SURVIVAL RATE; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0031054055     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00478-6     Document Type: Article

References (12)

1. Blanke, C.; Ansari, R.; Mantravadi, R.; Gonin, R.; Tokars, W.; Fisher W.; Pennington, K.; O'Connor, T.; Rynard, S.; Miller, M.; Einhorn, L. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable nonsmall cell lung cancer: A Hoosier Oncology Group protocol. J. Clin. Oncol. 13:1425-1429; 1995.
2. Byhardt, R. W.; Scott, C. B.; Ettinger, D. S.; Curran, W. J.; Scotte Doggett, R. L.; Coughlin, C.; Scarantino, C.; Rotman, M.; Emami, B. Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Cancer 75:2337-2344; 1995.
3. Dajczman, E.; Srolovitz, H.; Kreisman, H.; Frank, H. Fatal pulmonary toxicity following oral etoposide therapy. Lung Cancer 12:81-86; 1995.
4. Dillman, R. O.; Seagren, S. L.; Herndon, J.; Green, M. R. Randomized trial of induction chemotherapy plus radiation vs. RT alone in stage III nonsmall cell lung cancer: Five year follow-up of CALGB 84-33 (abstr 1092). Proc. Am. Soc. Clin. Oncol. 12:329; 1993.
5. Friess, G. C.; Baikadi, M.; Harvey, W. H. Concurrent cisplatin and etoposide with radiotherapy in locally advanced nonsmall cell lung cancer. Cancer Treat. Rep. 71:681-684; 1987.
6. Kubota, K.; Kiyoyuki, F.; Kawahara, M.; Kodama, N.; Yamamoto, M.; Ogawara, M.; Negoro, S.; Masuda, N.; Takada, M.; Matsui, K.; Takifuji, N.; Kudoh, S.; Kusunoki, Y.; Fukuoka, M. Role of radiotherapy in combined modality treatment of locally advanced nonsmall cell lung cancer. J. Clin. Oncol. 12:1547-1552; 1994.
7. Lee, J. S.; Scott, C.; Komaki, R.; Fossella, F.; Dundas, G. S.; McDonald, S.; Palmer, M.; Curran, W. J.; Byhardt, R. W. Concurrent chemoradiation therapy with oral VP-16 and cisplatin for locally advanced inoperable nonsmall cell lung cancer (NSCLC): RTOG Protocol 91-06. Proc. Am. Soc. Clin. Oncol. 13:363; 1994.
8. Perez, C.; Bauer, M.; Edelstein, S.; Gillespie, B.; Birch, R. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int. J. Radiat. Oncol. Biol. Phys. 32:539-547; 1986.
9. Roach, M.; Gandara, D. R.; Yuo, H.-S.; Swift, P. S.; Kroll, S.; Shrieve, D. C.; Wara, W. M.; Margolis, L.; Phillips, T. L. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J. Clin. Oncol. 13:2606-2612; 1995.
10. Sause, W. T.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Emami, B.; Curran, W. J.; Byhardt, R. W.; Turrisi, A. T.; Dar, R.; Cox, J. D. Radiation Therapy Oncology Group 88-08 and Eastern Cooperative Oncology Group 4588: Preliminary results of a phase III trial in regionally advanced, unresectable nonsmall-cell lung cancer. J. Natl. Cancer Inst. 87:198-205; 1995.
11. Schaake-Koning, C.; van den Bogaert, W.; Dalesio, O.; Festen, J.; Hoogenhout, J.; van Houtte, P.; Kirkpatrick, A.; Koolen, M.; Maat, B.; Nijs, A.; Renaud, A.; Rodrigus, P.; Schuster-Uitterhoeve, L.; Sculier, J.-P.; van Zandwijk, N.; Bartelink, H. Effects of concomitant cisplatin and radiotherapy on inoperable nonsmall cell lung cancer. N. Engl. J. Med. 326:524-530; 1992.
12. Tróvo, M. G.; Minatel, E.; Franchin, G.; Boccieri, M. G.; Nascimben, O.; Bolzicco, G.; Pizzi, G.; Torreta, A.; Veronesi, A.; Gobitti, C.; Zanelli, D. J.; Monfardini, S. Radiotherapy vs. radiotherapy enhanced by cisplatin in stage III nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 24:11-15; 1992.